FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System

K Number: K253737 · Decision Feb 3, 2026
Classifications
1
FEI Numbers
31
Registration Numbers
31
Same Product Code
17
Applicant Total
27
Review Days
71

Basic Information

Device Name
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System
K Number
K253737
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1355
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Dexcom, Inc.
Date Received
November 24, 2025
Decision Date
February 3, 2026
Product Code
QBJ
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QBJ Integrated Continuous Glucose Monitoring System, Factory Calibrated

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QBJ), ordered by most recent decision date.

View all

Other Clearances by Dexcom, Inc.

K Number Device Name
K260935 Stelo Glucose Biosensor System
K261402 Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System
K261359 Stelo Glucose Biosensor System
K253710 Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System
K252818 Dexcom Smart Basal
K243214 Dexcom G7 15 Day Continuous Glucose Monitoring System
K240902 Dexcom G7 Continuous Glucose Monitoring System
K234070 Stelo Glucose Biosensor System
K234133 Dexcom G7 Continuous Glucose Monitoring System
K231081 Dexcom G7 Continuous Glucose Monitoring (CGM) System
Search all 27 clearances from Dexcom, Inc. →